MONCTON, NEW BRUNSWICK--(Marketwired - Feb. 24, 2016) - OrganiGram Holdings Inc. (TSX VENTURE:OGI)(OTCQB:OGRMF) (the "Company") is pleased to announce that they have received approval from Health Canada for the production of cannabis oils.

"With the approval of our production license we will soon be able to supply an organic oils solution to our clientele. With the continued growth of our customer base we are aware of the demand for an organic alternative which will complement our existing product line," said Roger Rogers.

We are also pleased to announce that two new members have joined the OrganiGram team:

• Larry Rogers, as Chief Operating Officer
Mr. Rogers was the Chief Executive Officer and co-founder of CLS Lexi-tech Ltd., Canada's largest private language service provider. He began his career in the information technology field, before going on to play a key role in the creation and growth of Lexi-tech International Inc., first as Vice-President Operations then as President from 2001. Mr. Rogers holds a Bachelor of Science Degree, with a major in computer science degree from the University of New Brunswick.
• Raymond Gracewood, as Chief Commercial Officer
As the previous Senior Director of Sales and Marketing for Moosehead Breweries Ltd., Mr. Gracewood is a leading brand and marketing professional in Atlantic Canada. With more than 15 years' experience in the marketing space, he is a strong speaker on brand, packaging and positioning, both locally and throughout North America. He has extensive experience in building and developing brands, positioning and segmentation. Mr. Gracewood holds a Bachelor of Business Administration degree, from the University of New Brunswick.

"Great management, along with dedicated employees remains the key to success in any business. Organigram is excited to add these two proven executives to its Team, and looks forward to implementing its business plan for recreational legalization," said Denis Arsenault, CEO.

About Organigram Holdings Inc.

Organigram Holdings Inc. is a TSX Venture Exchange listed company who's wholly owned subsidiary, Organigram Inc., is a licensed producer of medical marijuana in Canada. Organigram is focused on producing the highest quality, condition specific medical marijuana for patients in Canada. Organigram's facility is located in Moncton, New Brunswick and the Company is regulated by the Marihuana for Medical Purposes Regulations.

On behalf of the board of directors,

Denis Arsenault, Director and CEO, OrganiGram Holdings Inc.

For further information, please visit

The TSX Venture Exchange Inc. has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release.

This news release contains forward-looking information, which involves known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectation. Important factors - including the availability of funds, the results of financing efforts, crop yields - that could cause actual results to differ materially from the Company's expectations are disclosed in the Company's documents filed from time to time on SEDAR (see Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact Information:

OrganiGram Holdings Inc.
Giselle Doiron
Director of Investor and Media Relations
(506) 801-8986